Research Article
High Expression of JMJD4 Is a Potential Diagnostic and Prognostic Marker of Renal Cell Carcinoma
Table 1
Clinical characteristics of ccRCC patients.
| Characteristic | Levels | Overall |
| | | 539 |
| T stage, (%) | T1 | 278 (51.6%) | T2 | 71 (13.2%) | T3 | 179 (33.2%) | T4 | 11 (2%) |
| N stage, (%) | N0 | 241 (93.8%) | N1 | 16 (6.2%) |
| M stage, (%) | M0 | 428 (84.6%) | M1 | 78 (15.4%) |
| Pathologic stage, (%) | Stage I | 272 (50.7%) | Stage II | 59 (11%) | Stage III | 123 (22.9%) | Stage IV | 82 (15.3%) |
| Primary therapy outcome, (%) | PD | 11 (7.5%) | SD | 6 (4.1%) | PR | 2 (1.4%) | CR | 128 (87.1%) |
| Gender, (%) | Female | 186 (34.5%) | Male | 353 (65.5%) |
| Race, (%) | Asian | 8 (1.5%) | Black or African American | 57 (10.7%) | White | 467 (87.8%) |
| Age, (%) | ≤60 | 269 (49.9%) | >60 | 270 (50.1%) |
| Histologic grade, (%) | G1 | 14 (2.6%) | G2 | 235 (44.3%) | G3 | 207 (39%) | G4 | 75 (14.1%) |
| Age, median (IQR) | | 61 (52, 70) |
|
|